Details of the Drug Formulations

General Information of Drug (ID: DMMC4BY)

Drug Name
Brominide tartrate Drug Info
Synonyms
BRIMONIDINE TARTRATE; 70359-46-5; Brimonidine tartarate; Alphagan; Brimonidine D-tartrate; UNII-4S9CL2DY2H; Brimonidinne tartrate; C11H10BrN5.C4H6O6; Brimonidine L-Tartrate; Brimonidine (tartrate); Brimonidine D-tartarate; 79570-19-7; 4S9CL2DY2H; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate; UK-14304-18; Qoliana; brimonidine Purite; Brimonidine tartrate [USAN]
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
54405
CAS Number
70359-46-5
TTD ID
D00ARM
ACDINA ID
D00893

Full List of Drug Formulations Containing This Drug

Brimonidine Tartrate 0.2% solution
Company Formulation ID FDA Description
Allergan F23653 Benzalkonium Chloride; Citric Acid; Polyvinyl Alcohol; Sodium Chloride; Sodium Citrate; Purified Water
------------------------------------------------------------------------------------
Brimonidine Tartrate 0.15% solution
Company Formulation ID FDA Description
Sandoz F23654 Povidone; Boric Acid; Sodium Borate; Calcium Chloride; Magnesium Chloride; Potassium Chloride; Mannitol; Sodium Chloride; Purified Water
------------------------------------------------------------------------------------
Brimonidine Tartrate 0.025% solution
Company Formulation ID FDA Description
Bausch & Lomb orporated F23652 Benzalkonium Chloride; Boric Acid; Calcium Chloride Dihydrate; Glycerin; Potassium Chloride; Sodium Borate Decahydrate; Sodium Chloride; Water
------------------------------------------------------------------------------------

References

1 Alpha(2A)-adrenoceptor: G(alphai1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway. Biochem Pharmacol. 2000 Jun 15;59(12):1531-8.